Trimipramine in primary insomnia: Results of a polysomnographic double-blind controlled study

Pharmacopsychiatry

Volumn 35, Issue 5, 2002, Pages 165-174

  Riemann, D ^a   Voderholzer, U ^a   Cohrs, S ^b   Rodenbeck, A ^b   Hajak, G ^b   Ruther E ^b   Wiegand, M H ^c   Laakmann, G ^d   Baghai, T ^d   Fischer, W ^e   Hoffmann, M ^f   Hohagen, F ^g   Mayer, G ^h   Berger, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g UNIVERSITY OF LÜBECK   (Germany)

^h Neurological Hospital Hephata   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DOXEPIN; LORMETAZEPAM; PLACEBO; TRIMIPRAMINE;

ACCOMMODATION PARALYSIS; ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HANGOVER; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OUTPATIENT; PHASE 3 CLINICAL TRIAL; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REBOUND; REM SLEEP; REM SLEEP DEPRIVATION; SAMPLE SIZE; SLEEP PARAMETERS; SLEEP PATTERN; SLEEP STAGE; SLEEP TIME; SLOW WAVE SLEEP; SOMNOLENCE; VERTIGO; WAKEFULNESS; XEROSTOMIA;

ADULT; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BENZODIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LORAZEPAM; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP STAGES; SLEEP, REM; TREATMENT OUTCOME; TRIMIPRAMINE;

EID: 18644379522     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34119     Document Type: Article

References (54)

1. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, third edition revised (DSM-III-R). Washington: 1987 Deutsche Bearbeitung: Wittchen, HU, Zaudig, M. Koehler, K, Saß. H. Weinheim, Beltz: 1989
2. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, fourth edition. Washington: APA, 1994 Deutsche Bearbeitung: Wittchen, HU, Zaudig, M, Koehler, K, Saß. H. Weinheim: Beltz, 1994
3. Armitage R, Rush J, Trivedi M, Cain J, Roffwarg HP. The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology 1994; 10: 123-127
4. Armitage R, Yonkers K, Cole D, Rush J. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients. J Clin Psychopharmacol 1997; 17: 161-168
5. Backhaus J, Hohagen F, Voderholzer U, Riemann D. Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia. Eur Arch Psychiatry Clin Neurosci 2001; 251: 35-41
6. Berger M, Riemann D. REM sleep in depression - an overview. J Sleep Res 1993; 2: 211-223
7. Berger M, Gastpar M. Trimipramine: a challenge to current concepts on antidepressives. Eur Arch Psychiatry Clin Neurosci 1996; 246: 235-239
8. Borbély AA, Loepfe M, Mattmann P, Tober I. Midazolam and triazolam: hypnotic action and residual effects after a single bedtime dose. Arzneimittelforschung 1983; 33: 1500-1502
9. Borbély AA, Mattmann P, Loepfe M, Strauch I, Lehmann D. Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum Neurobiol 1985; 4: 189-194
10. Buysse D, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213
11. Feige B, Voderholzer U, Riemann D, Hohagen F, Berger M. Independent sleep EEG slow wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects. Clin Neurophysiology 1999; 110: 1965-1974
12. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention. J Am Med Assoc 1989; 262: 1479-1484
13. Gillin JC, Rapaport M, Erman MK, Winokur A, Albala BJ. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: A double-blind, 8-week clinical trial. J Clin Psychiatry 1997; 58: 185-192
14. Görtelmeyer R. Schlaffragebogen SF-A and SF-B. In Collegium Internationale Psychiatriae Scolarum (CIPS). Herausgeber. Internationale Skalen für Psychiatrie. Weinheim: Beltz, 1981
15. Hajak G, Rüther E. Insomnie. Berlin: Springer, 1995
16. Hajak G, Rodenbeck A, Voderholzer U, Riemann D, Cohrs S, Hohagen F, Berger M, Rüther E. Doxepin in the treatment of primary insomnia - a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001; 62: 453-463
17. Hohagen F, Rink K, Käppler C, Schramm E, Riemann D, Weyerer S, Berger M. Prevalence and treatment of insomnia in general practice. Eur Arch Psychiatry Clin Neurosci 1993; 242: 329-336
18. Hohagen F, Fritsch Montero R, Weiss E, Lis S, Schönbrunn E, Dressing H, Riemann D, Berger M. Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics? Eur Arch Psychiatry Clin Neurosci 1994; 244: 65-72
19. Hohagen F, Käppler C, Schramm E, Rink K, Weyerer S, Riemann D, Berger M. Prevalence of insomnia in elderly general practice attenders and the current treatment modalities. Acta Psychiat Scand 1994; 90: 102-108
20. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000; 162: p 225-233
21. Kales A, Bixler EO, Soldatos CR, Mitsky DJ. Kales JD. Dose-response studies of lormetazepam: Efficacy, side effects, and rebound insomnia. J Clin Pharmacol 1982; 22: 520-530
22. Kripke DF. Chronic hypnotic use: deadly risks, doubtful benefit. Sleep Med Rev 2000; 4: 5-20
23. Mashiko H, Niwa S-I, Kumashiro H, Kaneko Y, Suzuki S, Numata Y, Horikoshi R, Watanabe Y. Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: Dose-finding study with no concomitant use of hypnotic agent. Psychiat Clin Neurosci 1999; 53: 193-194
24. Merz W, Ballmer U. Symptoms of the barbiturate/benzodiazepine withdrawal syndrome in healthy volunteers: Standardized assessment by a newly developed self-rating scale. J Psychoactive Drugs 1983; 15: 71-84
25. Montgomery SA, Asberg M. Montgomery-Asberg Depression Rating Scale. In Collegium Internationale, European Edition (CIPS), editors. Rating Scales for Psychiatry Weinheim: Beltz Test GmbH, 1986
26. Morin CM. Insomnia - Psychological assessment and management. New York: The Guilford Press, 1993
27. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy. Am J Psychiatry 1994; 151: 1172-1180
28. Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: A meta-analysis. J Consult Clin Psychology 1995; 63: 79-89
29. Nair NP, Amin M, Schwartz G, Dastoor D, Thavundayil JX, Mirmiran J, MacDonald C, Phillips R. A comparison of the cardiac safety and therapeutic efficacy of trimi-pramine versus doxepin in geriatric depressed patients. J Am Geriatr Soc 1993; 41: 863-867
30. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF, Kupfer D. Benzodiazepines and zolpidem for chronic insomnia. JAMA 1997; 278: p 2170-2177
31. Nowell PD, Reynolds CF, Buysse DJ, Dew MA, Kupfer DJ. Paroxetine in the treatment of primary insomnia: Preliminary clinical and electroencephalogram sleep data. J Clin Psychiatry 1999; 60: 89-95
32. Perlis ML, Giles DE, Mendelson WB, Bootzin RR. Wyatt JK. Psychophysiological insomnia: The behavioural model and a neurocognitive perspective. J Sleep Res 1997; 6: 179-188
33. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Washington, DC: US Government Printing Office, Public Health Service, 1968
34. Riemann D, Löw H, Schredl M, Wiegand M, Dippel B, Berger M. Investigations of morning and laboratory dream recall and content in depressive patients during baseline condition and under antidepressive treatment with trimipramine. Psychiat J Univ Ottawa 1990; 15: 93-99
35. Riemann D, Backhaus J. Behandlung von Schlafstörungen - Ein psychologisches Gruppenprogramm. Weinheim: Beltz, 1996
36. Riemann D. Berger M. Sleep disorders and mental disorders. Curt Opin Psychiat 1998; 11: 327-331
37. Riemann D, Berger M, Voderholzer U. Sleep and depression - results from psychobiological studies: an overview. Biol Psychology 2001; 57: 67-103
38. Sandor P, Shapiro CM. Sleep patterns in depression and anxiety: Theory and pharmacological effects. J Psychosom Res 1994; 38: 125-139
39. Schramm E, Hohagen F, Grasshoff U, Riemann D, Hajak G, Weeß H-G, Berger M. Test-retest reliability and validity of the Structured Interview for Sleep Disorders according to DSM-III-R. Am J Psychiatry 1993; 150: 867-872
40. Schramm E, Hohagen F, Käppler C, Grasshoff U, Berger M. Psychiatric comorbidity of insomnia in general practice attenders using DSM-III-R. Acta Psychiat Scand 1995; 91: 16-17
41. Schwabe U, Paffrath D. Arzneiverordnungs-Report 1999 - Aktuelle Daten, Kosten, Trends und Kommentare. Berlin, Heidelberg, New York: Springer, 2000
42. Simen S, Hajak G, Schlaf G, Westenhöfer J, Rodenbeck A, Band B, Pudel V, Rüther E. Chronifizierung von Schlafbeschwerden. Nervenarzt 1995; 66: 686-695
43. Smith MT. Perils ML, Park A, Smith MS, Pennington J, Giles DE, Buysse DJ. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002; 159: 5-11
44. Sonntag A, Rothe B, Guldner J, Yassouridis A, Holsboer F, Steiger A. Trimipra-mine and imipramine exert different effects on the sleep EEG and on nocturnal hor- mone secretion during treatment of major depression. Depression 1996; 4: 1-13
45. Vogel GW. Sleep laboratory study of lormetazepam in older insomniacs. In Hindmarch, I, Ott H, Roth T, editors. Sleep laboratory study of lormetazepam in older insomniacs Berlin-Heidelberg: Springer-Verlag, 1984: pp. 69-78
46. Walsh JK, Schweitzer PK, Ten-year trends in the pharmacological treatment of insomnia. Sleep 1999; 22: 371-375
47. Ware JC, Brown FW, Moorad PJ, Pittard JT, Cobert B. Effects on sleep: A double-blind study comparing trimipramine to imipramine in depressed insomniac patients. Sleep 1989; 12: 537-549
48. Ware JC, Pittard JT. Increased deep sleep after trazodone use: A double-blind placebo-controlled study in healthy young adults. J Clin Psychiatry 1990; 51: 18-22
49. Weyerer S, Dilling H. Prevalence and treatment of insomnia in the community: Results from the upper bavarian field study. Sleep 1991; 14: 392-398
50. Wiegand M, Berger M, Zulley J, von Zerssen D. The effect of trimipramine on sleep in patients with major depressive disorder. Pharmacopsychiatry 1986; 19: 198-199
51. Wiegand M, Berger M. Action of trimipramine on sleep and pituitary hormone secretion. Drugs 1989; 38: 35-42
52. Wittchen HU, Krause P, Höfler M, Pittrow D, Winter S, Spiegel B, Hajak G, Riemann D, Steiger A. Pfister H. NISAS-2000 - Die 'Nationwide Insomnia Screening and Awareness Study' - Prävalenz und Verschreibungsverhalten in der allgemeinärztlichen Versorgung, Fortschr Med 2001; 1:1-11
53. Wittchen HU, Krause P, Höfler M, Winter S, Spiegel B, Hajak G, Riemann D, Pittrow D, Steiger A, Pfister H. NISAS-2000 - Die 'Nationwide Insomnia Screening and Awareness Study' - Insomnien und Schlafstörungen in der allgemeinärztlichen Versorgung. Nervenheilkunde 2001; 20:4-16
54. Wolf R, Dykierek P, Gattaz WF, Maras A, Kohnen R, Dittmann RW, Geuppert M, Riemann D, Berger M. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression. Pharmacopsychiatry 2001; 34:1-6